Use of anti-claudin-1 antibodies to treat cholangiopathies
US-2026055179-A1 · Feb 26, 2026 · US
This page is not indexed by search engines while we improve data quality.
Alentis Therapeutics Ag patents
Alentis Therapeutics Ag holds 4 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 4 |
| Recent patents | 3 |
| First publication | May 4, 2023 |
| Latest publication | Feb 26, 2026 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Treatment of drug-resistant hepatocellular carcinoma
US-2026015416-A1 · Jan 15, 2026 · US
Use of anti-claudin-1 antibodies to treat cholangiocarcinoma
US-2025326835-A1 · Oct 23, 2025 · US
Anti-claudin-1 monoclonal antibodies for the prevention and treatment of fibrotic diseases
US-2023138047-A1 · May 4, 2023 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Use of anti-claudin-1 antibodies to treat cholangiopathies
US-2026055179-A1 · Feb 26, 2026 · US
Treatment of drug-resistant hepatocellular carcinoma
US-2026015416-A1 · Jan 15, 2026 · US
Use of anti-claudin-1 antibodies to treat cholangiocarcinoma
US-2025326835-A1 · Oct 23, 2025 · US
Anti-claudin-1 monoclonal antibodies for the prevention and treatment of fibrotic diseases
US-2023138047-A1 · May 4, 2023 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 4 |
| Chemistry & Metallurgy | 4 |